HALF BAK’D has authored a new report on the state of CBD legalization in 2025 and on recent scientific research studies into its medicinal purposes.
-- HALF BAK’D has authored a new report on hemp-derived CBD titled ‘CBD in 2025: Safety, Latest Science & Legal Status Explained’ that covers the state of CBD legality, research, and use in the United States in 2025.
More information is available at https://half-bakd.com/blogs/news/cbd-in-2025-safety-latest-science-legal-status-explained?srsltid=AfmBOop3mZhcmVDcwJ64ALXOqtFscJK2fUuYQ3kb7Jng_nR70D4m-T3N
HALF BAK’D is committed to improving the American public’s understanding of CBD. In a culture that broadly either demonizes the drug, or glorifies it, they seek to publish well-researched, accurate, and accessible reports in terms that demystify it and improve literacy surrounding it.
As such, their report outlines the current legal status of hemp-derived CBD in the United States, highlighting the fact that the regulatory landscape is still in evolution as of 2025.
While CBD products with under 0.3% THC on a dry weight basis are now federally legal under the 2018 Farm Bill, the FDA has not yet established comprehensive regulations for its use in food, beverages, or supplements, leaving states to implement their own policies. This has resulted in a fragmented legal environment where CBD’s availability and permitted uses vary widely by location.
As HALF BAK’D cautions, this means end-point consumers must do their due diligence before purchasing any CBD products.
The other focus of HALF BAK’D’s report is on recent scientific research which is continuing to explore CBD’s therapeutic potential and safety profile following promising early uptake amongst chronic pain sufferers and cancer patients undergoing chemotherapy.
As they summarized, there are several current inquiries into the impacts of CBD on neurological conditions and behavioral disorders, including PTSD, autism spectrum disorder, and addiction disorders. More diverse studies—including one by the University of California—are also considering its benefits for patients with debilitating illnesses like AIDs.
HALF BAK’D’s report also reveals that, to date, the body of scientific work on CBD suggests that it is also generally well tolerated, though more long-term studies are needed to confirm its efficacy for these various conditions.
As such, their new report also notes that there is growing interest in standardizing product quality and dosage to better protect consumers, and they advocate for continued clinical trials to support responsible public health decisions.
As they summarized pithily in their advice for endpoint consumers, “Always choose CBD that comes with lab results, clean labeling, and clear sourcing. Talk to a doctor before using it, especially if you’re on other medication or managing a health issue. Rules around CBD change often, so double-check what’s allowed in your area. And be wary of miracle claims; stick to brands that follow science and stay transparent.”
For more information, visit https://half-bakd.com/blogs/news/cbd-in-2025-safety-latest-science-legal-status-explained?srsltid=AfmBOop3mZhcmVDcwJ64ALXOqtFscJK2fUuYQ3kb7Jng_nR70D4m-T3N
______________________________________________________
FDA Disclaimer: These statements have not been evaluated by the FDA. HALF BAK’D’s advice is not intended to diagnose, treat, cure, or prevent any disease.
______________________________________________________
Contact Info:
Name: Jordan Sigalos
Email: Send Email
Organization: HALF BAK'D
Address: 151 Kalmus Drive L3, Costa Mesa, CA 92626, United States
Phone: +1-800-251-2995
Website: https://half-bakd.com
Source: PressCable
Release ID: 89164057
If there are any deficiencies, problems, or concerns regarding the information presented in this press release that require attention or if you need assistance with a press release takedown, we encourage you to notify us without delay at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our diligent team is committed to promptly addressing your concerns within 8 hours and taking necessary actions to rectify any identified issues or facilitate the removal process. Providing accurate and trustworthy information is of utmost importance.
